Patel Jayendrakumar S, Kapadia Samir R
Section of Interventional Cardiology, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J2-3, Cleveland, OH 44195, USA.
Section of Interventional Cardiology, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J2-3, Cleveland, OH 44195, USA.
Interv Cardiol Clin. 2018 Oct;7(4):471-475. doi: 10.1016/j.iccl.2018.06.003. Epub 2018 Aug 11.
"In patients with coronary artery disease undergoing transcatheter aortic valve replacement (TAVR), the decision of whether to revascularize, which lesions to revascularize, and the optimal timing of revascularization remains controversial. The sequence of revascularization should be made on a case-by-case basis. Pre-TAVR revascularization (staged or simultaneous with TAVR) is preferred due to unobstructed access to coronary ostia and is important to consider especially in cases in which long self-expanding valves are used. In patients who are hemodynamically compromised, the valve should be addressed first, as the most important cause of mortality is heart/multiorgan failure."
在接受经导管主动脉瓣置换术(TAVR)的冠心病患者中,是否进行血运重建、对哪些病变进行血运重建以及血运重建的最佳时机仍存在争议。血运重建的顺序应根据具体情况决定。由于可通畅进入冠状动脉开口,TAVR前血运重建(分期或与TAVR同时进行)更为可取,尤其在使用长自膨胀瓣膜的情况下,这一点很重要。对于血流动力学不稳定的患者,应首先处理瓣膜问题,因为死亡的最重要原因是心脏/多器官衰竭。